Optimal Management of the Critically Ill: Anaesthesia, Monitoring, Data Capture, and Point-of-Care Technological Practices in Ovine Models of Critical Care

Abstract

Animal models of critical illness are vital in biomedical research. They provide possibilities for the investigation of pathophysiological processes that may not otherwise be possible in humans. In order to be clinically applicable, the model should simulate the critical care situation realistically, including anaesthesia, monitoring, sampling, utilising appropriate personnel skill mix, and therapeutic interventions. There are limited data documenting the constitution of ideal technologically advanced large animal critical care practices and all the processes of the animal model. In this paper, we describe the procedure of animal preparation, anaesthesia induction and maintenance, physiologic monitoring, data capture, point-of-care technology, and animal aftercare that has been successfully used to study several novel ovine models of critical illness. The relevant investigations are on respiratory failure due to smoke inhalation, transfusion related acute lung injury, endotoxin-induced proteogenomic alterations, haemorrhagic shock, septic shock, brain death, cerebral microcirculation, and artificial heart studies. We have demonstrated the functionality of monitoring practices during anaesthesia required to provide a platform for undertaking systematic investigations in complex ovine models of critical illness.

Characterisation of the circulating acellular proteome of healthy sheep using LC-MS/MS-based proteomics analysis of serum

“…The sheep were reared according to established standard operating procedures, described elsewhere [33]. Sample aliquots of 500 μL were stored in 1.5 mL Eppendorf tubes at -80 °C at the ARCBS, Brisbane.…”

Perspectives on adjunctive use of ketamine for analgosedation during extracorporeal membrane oxygenation

“…Most recently, Cheng et al [8] published an excellent review article, summarizing the present literature on antimicrobials, sedatives, and analgesics during ECMO. They clearly delineated the PK/PD of several drugs based on their group's extensive contribution to pharmacological research in ex vivo models with ECMO circuits and in vivo using large animal models of ECMO [9]. Following their substantial work in this field, we would like to give a clinical perspective on analgosedation during ECMO support.…”

Proteogenomics of selective susceptibility to endotoxin using circulating acute phase biomarkers and bioassay development in sheep: a review

“…Heightened interest in the understanding of sheep has led to new evidence that supports their relevance and suitability as experimental models for understanding critical illnesses in humans as recently reviewed in related studies [129]. Improved production traits in meat, milk and fine wool currently constitute the predominant spectrum of the phenotypes of modern breeds of sheep at the expense of original strains [7].…”